Disruption of the RanBP17/Hox11L2 region by recombination with the TCRδ locus in acute lymphoblastic leukemias with t(5;14)(q34;q11)

Leukemia

Volumn 16, Issue 11, 2002, Pages 2205-2212

  Hansen Hagge, T E ^a,e   Schafer M ^b   Kiyoi, H ^a,f   Morris, S W ^c   Whitlock, J A ^d   Koch, P ^b   Mahotka, C ^a,g   Bartram, C R ^a,b   Janssen, J W G ^a,b  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^e HUMBOLDT UNIVERSITY   (Germany)

^f NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Acute lymphoblastic leukemia; Chromosomal translocation; Hox1L2; RanBP17; T cell receptor

Indexed keywords

COMPLEMENTARY DNA; GENOMIC DNA; HOMEODOMAIN PROTEIN; HOX PROTEIN; KARYOPHERIN BETA; PRIMER DNA; RAN PROTEIN; T LYMPHOCYTE RECEPTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CHROMOSOME 14; CHROMOSOME 5; CHROMOSOME ANALYSIS; CHROMOSOME IDENTIFICATION; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; CHROMOSOME TRANSLOCATION 14Q11; CHROMOSOME TRANSLOCATION 5Q33; CHROMOSOME TRANSLOCATION 5Q34; CONTROLLED STUDY; DATA BASE; DNA ISOLATION; DNA LIBRARY; EXON; EXPRESSED SEQUENCE TAG; GENBANK; GENE LOCUS; GENE MAPPING; GENE SEQUENCE; GENE TARGETING; GENE TRANSLOCATION; GENETIC CODE; GENETIC RECOMBINATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BINDING; SEQUENCE ANALYSIS; TESTIS;

EID: 0036849635     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402671     Document Type: Article

References (50)

1. Klein G. Immunoglobulin gene-associated chromosomal translocations in B-cell derived tumors. Curr Top Microbiol Immunology 1999; 246: 161-167.
2. Rabbitts TH. Chromosomal translocations in human cancer. Nature 1994; 372: 143-149.
3. Look AT. Oncogenic transcription factors in the human acute leukemias. Science 1997; 278: 1059-1064.
4. Janssen JWG, Vaandrager J-W, Heuser T, Jauch A, Kluin PM, Geelen E, Bergsagel PL, Kuehl WM, Drexler HG, Otsuki T, Bartram CR, Schuuring E. Concurrent activation of a novel putative transforming gene, myeov, and cyclinDl in a subset of multiple myeloma cell lines with t(11;14)(q13;q32). Blood 2000; 95: 2691-2698.
5. Willis TG, Jadayel DM, Du M-Q, Peng H, Perry AR, Abdul-Rauf M, Price H, Karran L, Majekodunmi O, Wlodarska I, Pan L, Crook T, Hamoudi R, Isaacson PG, Dyer. Bcl10 is involved in t(1;14)(p22;q32) of MALT B Cell lymphoma and mutated in multiple tumor types. Cell 1999; 96: 35-45.
6. Zhang Q Siebert R, Yan M, Hinzmann B, Cui X, Xue L, Rakestraw KM, Naeve CW, Beckmann G, Weisenburger DID, Sanger WG, Nowotny H, Vesely M, Callet-Bauchu E, Salles G, Dixit VM, Rosenthal A, Schlegelberger B, Morris SW. Inactivating mutations and overexpression of BCL1O, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nat Genet 1999; 22: 63-68.
7. Richelda R, Ronchetti D, Baldini L, Cro L, Viggiano L, Marzella R, Rocchi M, Otsuki T, Lombardi L, Maiolo AT, Neri A. A novel chromosomal translocation t(4;14)(p16.3;q32) in multiple myeloma involves the fibroblast growth-factor receptor 3 gene. Blood 1997; 90: 4062-4070.
8. Chesi M, Nardini F, Brents LA, Schrock E, Ried T, Kuehl WM, Bergsagel PL. Frequent translocation t(4;1 4)(p16.3,-q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nat Genet 1997; 16: 260-264.
9. Whitlock JA, Raimondi SC, Harbott J, Morris SW, McCurley TL, Hansen-Hagge TE, Ludwig WD, Weimann G, Bartram CR. t(5;14)(q33-34;q11), a new recurring cytogenetic abnormality in childhood acute leukemia. Leukemia 1994; 8: 1539-1543.
10. Janssen JWG, Braunger J, Ballas K, Faust M, Siebers U, Steenvoorden ACM, Bartram CR. Spectrum of transforming sequences detected by tumorigenicity assay in a large series of human neoplasms. Int J Cancer 1999; 80: 857-862.
11. Boehm T, Baer R, Lavenir I, Forster A, Waters JJ, Nacheva E, Rabbitts TH. The mechanism of chromosomal translocation t(11;14) involving the T cell receptor C delta locus on human chromosome 14q11 and a transcribed region of chromosome 11p15. EMBO J 1988; 7: 385-394.
12. Sealey PC, Whittaker PA, Southern EM. Removal of repeated sequences from hybridisation probes. Nucleic Acids Res 1985; 13: 1905-1922.
13. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
14. Shackleford GM, Varmus HE. Expression of the proto-oncogene int-1 is restricted to postmeiotic male germ cells and the neural tube of mid-gestational embryos. Cell 1987; SO: 89-95.
15. Natarajan D, Boulter CA. Isolation of genomic sequences flanking a retroviral insertion site using a novel PCR-based method. Gene 1995; 161: 195-198.
16. Davis LG, Dibner MD, Battey JF. Cloning DNA from the Eukaryotic Genome. In: Davis LG, Dibner MID, Battey JF (eds). Basic Methods in Molecular Biology. Elsevier: New York, 1986, pp. 167-191.
17. Hansen-Hagge TE, Janssen JWG, Hameister H, Papa FR, Zechner U, Seriu T, Jauch A, Becke D, Hochstrasser M, Bartram CR. An evolutionarily conserved gene on human chromosome 5q33-q34, UBH1, encodes a novel deubiquitinating enzyme. Genomics 1998; 49: 411-418.
18. Auch D, Reth M. Exon trap cloning: using PCR to rapidly detect and clone exons from genomic DNA fragments. Nucleic Acids Res 1990; 18: 6743-6744.
19. Nehls M, Pfeifer D, Boehm T. Exon amplification from complete libraries of genomic DNA using a novel phage vector with automatic plasmid excision facility: application to the mouse neurofibromatosis-1 locus. Oncogene 1994; 9: 2169-2175.
20. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higushi R, Horn GT, Mullis KB, Erlich HA. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239: 487-491.
21. Hansen-Hagge TE, Yokota S, Reuter HJ, Schwarz K, Bartram CR. Human common acute lymphoblastic leukemia-derived cell lines are competent to recombine their T cell receptor delta/alpha regions along a hierarchically ordered pathway. Blood 1992; 80: 2353-2362.
22. Furano AV, Usdin K. DNA 'fossils' and phylogenetic analysis. Using Ll (LINE-1, long interspersed repeated) DNA to determine the evolutionary history of mammals. J Biol Chem 1995; 270: 25301-25304.
23. Koch P, Bohlmann I, Schäfer M, Hansen-Hagge TE, Kiyoi H, Wilda M, Hameister H, Bartram CR, Janssen JWG. Identification of a novel putative Ran binding protein and its close homologue. Biochem Biophys Res Common 2000; 278: 241-249.
24. Kozak M. Interpreting cDNA sequences: some insights from studies on translation. Mamm Genome 1996; 7: 563-574.
25. Görlich D, Kutay U. Transport between the cell nucleus and the cytoplasm. Annu Rev Cell Dev Biol 1999; 15: 607-660.
26. Watson A, Smaldon N, Lucke R, Hawkins T. The Caenorhabditis elegans genome sequencing project: first steps in automation. Nature 1993; 362: 569-570.
27. Yancopoulos GD, DePinho RA, Zimmerman KA, Lutzker SG, Rosenberg N, Alt FW. Secondary genomic rearrangement events in pre-B cells: VHDJH replacement by a LINE-1 sequence and directed class switching. EMBO J 1986; 5: 3259-3266.
28. Pear WS, Nelson SF, Axelson H, Wahlstrom G, Bazin H, Klein G, Sumegi J. Aberrant class switching juxtaposes c-myc with a middle repetitive element (LINE) and an IgH intron in two spontaneously arising rat immunocytomas. Oncogene 1988; 2: 499-507.
29. Rabbitts PH, Douglas J, Fischer P, Nacheva E, Karpas A, Catovsky D, Melo JV, Baer R, Stinson MA, Rabbitts TH. Chromosome abnormalities at 11q13 in B cell tumours. Oncogene 1988; 3: 99-103.
30. Von Lindern M, Breems D, van Baal S, Adriaansen H, Grosveld G. Characterization of the translocation breakpoint sequences of two DEK-CAN fusion genes present in t(6;9) acute myeloid leukemia and a SET-CAN fusion gene found in a case of acute undifferentiated leukemia. Genes Chromosom Cancer 1992; 5: 227-234.
31. Miki Y, Nishisho I, Horii A, Miyoshi Y, Utsunomiya J, Kinzler KW, Vogelstein B, Nakamura Y. Disruption of the APC gene by a retrotransposal insertion of L1 sequence in a colon cancer. Cancer Res 1992; 52: 643-645.
32. Toriello HV, Glover TW, Takahara K, Byers PH, Miller DE, Higgins JV, Greenspan DS. A translocation interrupts the COL5A1 gene in a patient with Ehlers-Danlos syndrome and hypomelanosis of Ito. Nat Genet 1996; 13: 361-365.
33. Drechsler M, Royer-Pokora B. A LINE element present at the site of a 300-kb, deletion starting in intron 10 of the PAX6 gene in a case of familial aniridia. Hum Genet 1996; 98: 297-503.
34. Van de Water N, Williams R, Ockelford P, Browett P. A 20.7 kb deletion within the factor VIII gene associated with LINE-1 element insertion. Thromb Haemost 1998; 79: 938-942.
35. Kumatori A, Faizunnessa NN, Suzuki S, Moriuchi T, Kurozumi H, Nakamura M. Nonhomologous recombination between the cytochrome b558 heavy chain gene (CYBB) and LINE-1 causes an X-linked chronic granulomatous disease. Genomics 1998; 53: 123-128.
36. Segal Y, Peissel B, Renieri A, de Marchi M, Ballabio A, Pei Y, Zhou J. LINE-1 elements at the sites of molecular rearrangements in Alport syndrome-diffuse leiomyomatosis. Am J Hum Genet 1999; 64: 62-69.
37. Stochaj U, Rother KL. Nucleocytoplasmic trafficking of proteins: with or without Ran? BioEssays 1999; 21: 579-589.
38. Nakielny S, Dreyfuss G. Transport of proteins and RNAs in and out of the nucleus. Cell 1999; 99: 677-690.
39. Kraemer D, Wozniak RW, Blobel G, Radu A. The human CAN protein, a putative oncogene product associated with myeloid leukemogenesis, is a nuclear pore complex protein that faces the cytoplasm. Proc Natl Acad Sci USA 1994-91: 1519-1523.
40. Borrow J, Shearman AM, Stanton VP, Becher R, Collins T, Williams AJ, Dube I, Katz F, Kwong YL, Morris C, Ohyashiki K, Toyama K, Rowley J, Housman DE. The t(7;11)(p15;pl5) translocation in acute myeloid leukemia fuses the genes for nucleoporin NUP98 and class 1 homeoprotein HOXA9. Nat Genet 1996; 12: 159-167.
41. Nakamura T, Largaespada DA, Lee MP, Johnson LA, Ohyashiki K, Toyama K, Chen SJ, Willman CL, Chen IM, Feinberg AP, Jenkins NA, Copeland NG, Shaughnessy JD. Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;pl5) in human myeloid leukemia. Nat Genet 1996; 12: 154-158.
42. Raza-Egilmez SZ, Jani-Sait SN, Grossi M, Higgins MJ, Shows TB, Aplan PD. NUP98-HOXD13 gene fusion in therapy-related acute myelogenous leukemia. Cancer Res 1998; 58: 4269-4273.
43. Arai Y, Hosoda F, Kobayashi H, Arai K, Hayashi Y, Kamada N, Kaneko Y, Ohki M. The inv(11)(p15q22) chromosome translocation of de novo and therapy-related myeloid malignancies results in fusion of the nucleoporin gene, NUP98, with the putative RNA helicase, DDX10. Blood 1997; 89: 3936-3944.
44. Nakamura T, Yamazaki Y, Hatano Y, Miura I. NUP98 is fused to PMX1 homeobox gene in human acute myelogenous leukemia with chromosome translocation t(l;11)(q23;pl5). Blood 1999; 94: 741-747.
45. Hussey DJ, Nicola M, Moore S, Peters GB, Dobrovic A. The t(4;11)(q2l;pl5) translocation fuses the NUP98 and RAP1GADS1 genes and is recurrent in T cell acute lymphocytic leukemia. Blood 19991; 94: 2072-2079.
46. Buske C, Humphries RK. Homeobox genes in leukemogenesis. Int J Hematol 2000; 71: 301-308.
47. Bernard OA, Busson-LeConiat M, Ballerini P, Mauchauffé M, Della Valle V, Monni R, Nguyen Khac F, Mercher T, Penard-Lacronique V, Pasturaud P, Gressin L, Heilig R, Daniel M-T, Lessard M, Berger R. A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia. Leukemia 2001; 15: 1495-1504.
48. Bhoem T, Foroni L, Kaneko Y, Perutz ME, Rabbitts TH. The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T cell translocations to human chromosomes 11pl5 and 11p13. Proc Natl Acad Sci USA 1991, 88: 4367-4371.
49. Royer-Pokora B, Rogers M, Zhu TH, Schneider S, Loos U, Bolitz U. The TTG-2/RBTN2 T cell oncogene encodes two alternative transcripts from two promoters: The distal promoter is removed by most 11p13 translocations in acute T cell leukemia's (T-ALL). Oncogene 1995; 10: 1353-1360.
50. Ferrando AA, Neuberg DS, Staunton J, Loh ML, Huard C, Raimondi SC, Behm FG, Pui C-H, Downing JR, Gilliland DG, Lander ES, Golub TR, Look AT. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 2002; 1: 75-87.